Early work with ACE2 decoys against SARS‐CoV‐2 infection showed that simply linking ACE2 to an Fc domain inhibited infection in vitro with a modest EC50 of ~24 μg/mL, while retaining effector function of the Fc.13 The gene discussed is ACE2; the disease is infection.